My research interest is in understanding how mammals respond to virus infection, both at the cellular level and at the organism level. The interferon (IFN) system plays a major role in shaping the innate immune antiviral response and a focus of our research is on the analysis of the mechanism of IFN induction by virus infection; we are deciphering the signaling mechanism of Toll like receptor 3 and the RIG-I-like helicase receptors, which are activated by viruses. We uncovered an unexpected link between innate immunity and growth factor receptors by our observation that the EGF receptor is essential for TLR3 signaling. Another focus of our research is on understanding the mode of antiviral actions of a set of IFN-induced proteins, called IFITs.
Recently we have generated several mouse strains in which one or more IFIT genes have been knocked-out. Challenging these genetically modified mice with different viruses has revealed interesting and unexpected facets of IFN-action. It appears that a specific IFN-induced protein can inhibit the replication of only a limited set of viruses in a specific cell type. Thus, Ifit2, but not Ifit1, can inhibit the replication of vesicular stomatitis virus in neurons but not in other cell types. Another study has revealed that IRF-3, a transcription factor responsible inducing IFN synthesis, has an unrelated second function. Upon activation by virus infection, it triggers apoptosis by transporting the pro-apoptotic protein, Bax, to mitochondria. The apoptotic action of IRF-3, in addition to its transcriptional action, protects mice from viral pathogenesis.